Piramal Pharma Ltd. Share Price

trading near its 52 week breakout level.

trading near its 52 week breakout level. !PPLPHARMA is trading near its 52 week breakout level. • The 52-week breakout strategy focuses on stocks that cross their highest price of the past one year, often indicating strong bullish momentum and renewed buying interest. • When a stock moves above its 52-week high, it enters a zone with no previous resistance, which can support further upward movement if momentum continues. • Traders usually look for higher trading volumes, strong closing prices, and the stock trading above key moving averages to confirm the breakout. • Proper risk management is essential. A stop loss slightly below the breakout level helps limit downside risk while allowing traders to participate in potential trending moves. Disclaimer: Investments in securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. The above analysis is for educational and learning purpose. SEBI Registered Research Analyst: Vineet Ashwinikumar Chawla: INH000008190, BSE Enlistment No: 5433

PIRAMAL PHARMA BUYS MAJORITY STAKE IN YAPAN BIO

Piramal Pharma Acquires 40.67% Stake In Yapan Bio For ₹76 Crore, Making It Subsidiary

WATCH OUT FOR STOCKS IN NEWS

Watch out for the below mentioned stocks in news which are likely to be on spotlight for today the 14-Aug-2026 : - Piramal Pharma: An existing shareholder is likely to sell a 6 per cent stake in Piramal Pharma through block deals, with the offer size estimated at around Rs 1,750 crore, suggests some media reports citing sources. The deal may be offered at a minor discount to its previous close. Tata Motors Passenger Vehicles: The homegrown auto major reported a 80.2 per cent YoY fall in the net profit at Rs 775 crore, while revenue increased 9.3 per cent YoY to Rs 95,799 crore for the June 2026 quarter. Its EBITDA was down 20.4 per cent YoY to Rs 6,176 crore, while margins dropped to 6.5 per cent for the quarter. Max Financial Services: The life insurer reported total annualised premium equivalent (APE) of Rs 1,922 crore for the June 2026 quarter, while value of new business (VNB) stood at Rs 446 crore. Its VNB margin improved to 23.2 per cent, while retail APE came in at Rs 1,810 crore. Brigade Enterprises: The real estate developer reported a net profit of Rs 200.4 crore, while revenue stood at Rs 1,115.6 crore for the April-June 2026 period. Its EBITDA came in at Rs 361.4 crore, with margins improving to 32.4 per cent.

**Strategic MoU & Shareholding Update** **

PIRAMAL PHARMA: CO RESUMES OPERATIONS AT AHMEDABAD FACILITIES FOLLOWING FLOOD DISRUPTION